Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Researchers develop comprehensive framework to classify small-cell lung cancer

Researchers develop comprehensive framework to classify small-cell lung cancer

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Study uncovers why cancer patients with liver metastases have poor outcomes

Study uncovers why cancer patients with liver metastases have poor outcomes

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

New combination therapy has potential to treat aggressive cancers with common mutations

New combination therapy has potential to treat aggressive cancers with common mutations

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal model

New model can predict the risk of adverse side effects of cancer treatment

New model can predict the risk of adverse side effects of cancer treatment

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

MD Anderson presents positive clinical data from combination cancer therapies at SITC 2020

High dose radiation therapy linked to shorter survival times in NSCLC patients

High dose radiation therapy linked to shorter survival times in NSCLC patients

Study finds persistence of racial disparities in treatment for common lung cancer

Study finds persistence of racial disparities in treatment for common lung cancer

New tool can provide non-invasive decision support for NSCLC treatment

New tool can provide non-invasive decision support for NSCLC treatment

New study may lead to more effective, personalized cancer immunotherapies

New study may lead to more effective, personalized cancer immunotherapies

New initiative identifies key parameters underlying effective anti-tumor immunity

New initiative identifies key parameters underlying effective anti-tumor immunity

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Immunotherapy drug improves survival over standard chemotherapy for lung cancer patients

Immunotherapy drug improves survival over standard chemotherapy for lung cancer patients

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Targeted therapy found to be effective at shrinking tumors in patients with nonsmall-cell lung cancer

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Sotorasib phase 1 trial shows encouraging anti-cancer activity in lung, colorectal cancers

Targeted therapy improves disease-free survival in patients with early-stage NSCLC

Targeted therapy improves disease-free survival in patients with early-stage NSCLC